NYSE$AMWL
American Well Corp · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Announced results for the second quarter of 2024.
Amwell reported Q2 2024 financial results, showing progress in U.S. Military Health System deployment and improved adjusted EBITDA outlook due to cost alignment efforts. The company reiterated its 2024 revenue and visit guidance.
- Total Revenue was $62.8 million.
- Subscription revenue was $27.5 million.
- Amwell Medical Group (AMG) visit revenue was $28.7 million.
- Gross margin was 37%.
Headline financials
Revenue & EPS history
American Well · Revenue · Quarterly
$62.8M
Revenue by segment
American Well · $28.4M total across 1 segment · Q3 2023
- Subscription Revenue$28.4M-11.0%100.0%
Forward guidance
Amwell issued improved guidance by $10 million for 2024 Adjusted EBITDA, forecasting a range of between ($150) million to ($145) million from a previous range of between ($160) million to ($155) million. The company also reiterated its 2024 revenue and visit guidance, which calls for: •Revenue in the range of $259 to $269 million •AMG visits between 1.6 and 1.7 million
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
+1.4%
Avg return
Earnings day
+2.1%
Avg return
5 days after
-2.2%
Avg return
30 days after
41%
9 / 22 earnings
Positive
+33.8%
Q2 2024
Best reaction
-20.9%
Q1 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -2.0% | +27.2% | +34.0% | |
| Q4 2025 | +24.7% | +34.9% | +29.8% | |
| Q3 2025 | -9.5% | -20.0% | -20.6% | |
| Q1 2025 | +19.7% | +9.5% | +8.9% | |
| Q4 2024 | -5.0% | -3.6% | -35.5% | |
| Q3 2024 | -5.0% | -5.4% | -0.7% | |
| Q2 2024 | +33.8% | +13.9% | -1.1% | |
| Q1 2024 | +2.0% | +11.4% | -16.3% | |
| Q4 2023 | +23.6% | +20.8% | -16.0% | |
| Q3 2023 | +14.5% | +4.3% | +11.1% | |
| Q2 2023 | -8.3% | -13.9% | -35.2% | |
| Q1 2023 | -3.9% | -2.9% | +17.9% | |
| Q4 2022 | -13.1% | -19.2% | -37.3% | |
| Q3 2022 | -2.2% | +14.9% | -8.3% | |
| Q2 2022 | +9.2% | +6.8% | -4.8% | |
| Q1 2022 | -10.8% | +8.8% | +37.6% | |
| Q4 2021 | +7.2% | +1.0% | -8.0% | |
| Q3 2021 | -7.4% | -3.7% | -29.7% | |
| Q2 2021 | +0.7% | -1.7% | +0.8% | |
| Q1 2021 | -20.9% | -5.7% | +9.5% | |
| Q4 2020 | -4.1% | -10.8% | -1.5% | |
| Q3 2020 | -11.9% | -19.8% | +17.1% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro